The effects of PD-1/PD-L1 checkpoint inhibitors on recurrent/metastatic head and neck squamous cell carcinoma: a critical review of the literature and meta-analysis.

Clarke, Emily; Eriksen, Jesper Grau; Barrett, Sarah

Clarke, Emily; Eriksen, Jesper Grau; Barrett, Sarah.

Afiliación

Clarke E; Applied Radiation Therapy Trinity Discipline of Radiation Therapy, Trinity St James's Cancer Institute, Trinity College Dublin, Dublin, Ireland.
Eriksen JG; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
Barrett S; Applied Radiation Therapy Trinity Discipline of Radiation Therapy, Trinity St James's Cancer Institute, Trinity College Dublin, Dublin, Ireland.

Acta Oncol ; 60(11): 1534-1542, 2021 Nov.

Article en En | MEDLINE | ID: mdl-34410881

Asunto(s)

Antígeno B7-H1; Neoplasias de Cabeza y Cuello; Humanos; Recurrencia Local de Neoplasia/tratamiento farmacológico; Receptor de Muerte Celular Programada 1; Carcinoma de Células Escamosas de Cabeza y Cuello

Palabras clave

PD-1; PD-L1; Recurrent/metastatic head and neck squamous cell carcinoma; checkpoint inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antígeno B7-H1 / Neoplasias de Cabeza y Cuello Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Acta Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Irlanda

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google